• Теги
    • избранные теги
    • Компании928
      • Показать ещё
      • Показать ещё
      Международные организации23
      • Показать ещё
      Страны / Регионы261
      • Показать ещё
      • Показать ещё
      • Показать ещё
      • Показать ещё
28 июля, 16:52

C.R. Bard (BCR) Beats Earnings & Revenue Estimates in Q2

C.R. Bard's (BCR) solid performance in the Vascular, Urology and Surgical Specialties were the key highlights of the second quarter.

28 июля, 16:48

Align Technology (ALGN) Beats on Q2 Earnings and Revenues

Align Technology (ALGN) rides high in Q2 banking on robust growth in the Invisalign space.

27 июля, 20:55

Zimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales

Zimmer Biomet's (ZBH) Q2 earnings results disappoint with an unimpressive Knee, Hip and Dental performances.

27 июля, 19:02

Boston Scientific (BSX) Tops Q2 Earnings & Sales, View Up

Boston Scientific's (BSX) Q2 results gain on balanced segmental growth. Currency remains a dampener though.

27 июля, 15:02

Amedisys (AMED) Earnings & Revenues Miss Estimates in Q2

Strength in Hospice and Personal Care businesses offset the weakness in Amedisys' (AMED) Home Health Medicare business in Q2.

27 июля, 14:23

Edwards Lifesciences (EW) Tops Q2 Earnings & Sales, View Up

Edwards Lifesciences (EW) rides high on continued growth in its highly advanced Transcatheter Heart Valve space in Q2.

Выбор редакции
27 июля, 12:49

Zacks Podcast Highlights: Let's Make a Deal: What's a Merger Arbitrage Strategy?

Merger activity is increasing, and investors need to be prepared. This podcast discusses the 'merger arbitrage' strategy and what you need to know about this approach.

26 июля, 17:15

Thermo Fisher (TMO) Tops Q2 Earnings & Revenues, View Up

Thermo Fisher Scientific (TMO) continues to gain considerable synergies from FEI Company acquisition. A raised guidance buoys optimism.

Выбор редакции
25 июля, 19:56

I Loved Lucy review – Lucille Ball is diminished by this needy bioplay

Arts theatre, LondonSandra Dickinson’s heroic portrayal of the once world-famous TV comedian brings a pulse to this stage corpseAt the height of her success, Lucille Ball was the most famous woman on the planet. A newspaper suggested that her face was more familiar to the American public than Jesus Christ’s. Idi Amin was a huge fan. Reruns of the self-produced sitcom I Love Lucy, in which she and her husband Desi Arnaz played Lucy and Ricky Ricardo, a version of themselves, were still being screened long after the final episode of the six-year-long series was broadcast in 1957. There were endless spinoffs, keeping Ball working well into her 70s. Ball was ahead of her time. Washed-up in the movies, she spotted the potential of TV long before others working in Hollywood. She kept control by self-producing, and the studio she founded, Desilu, spawned other hits, including Star Trek and Mission: Impossible. She filmed in front of a live audience. She was married to a Cuban during an era when tensions between the US and Cuba were rising. Continue reading...

25 июля, 16:59

Quest Diagnostics (DGX) Tops Q2 Earnings, Raises '17 View

Quest Diagnostics (DGX) continues to ride high on its advanced diagnostic offerings. Also, a raised view buoys optimism.

25 июля, 15:12

Ecolab (ECL) to Report Q2 Earnings: Will It Pull a Surprise?

Despite an upbeat guidance, cutthroat competition in the niche space is likely to mar Ecolab's (ECL) growth in the second quarter.

24 июля, 17:29

Can Henry Schein (HSIC) Spring a Surprise in Q2 Earnings?

The timing of Good Friday is likely to dampen sales at Henry Schein (HSIC) in second-quarter 2017. Meanwhile, geographic expansion should continue.

24 июля, 17:29

Can Cerner (CERN) Deliver a Beat this Earnings Season?

We believe Cerner's (CERN) strong sales performance, solid portfolio and strategic initiatives have positioned it for stellar growth.

24 июля, 15:39

Can Illumina (ILMN) Spring a Surprise this Earnings Season?

Illumina (ILMN) is well poised to witness steady top-line growth in Q2. Yet, the bottom line may remain stressed.

21 июля, 16:28

Will Stryker (SYK) Deliver a Beat this Earnings Season?

The growing adoption of Stryker's (SYK) MAKO robots is expected to drive second-quarter 2017 sales in the orthopedic and reconstructive surgery market.

21 июля, 16:21

Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

Currency headwind is likely to dampen ResMed's (RMD) gains in the COPD and sleep apnea market.

21 июля, 15:54

McKesson (MCK) Q1 Earnings: Stock Likely to Beat Estimates?

McKesson's (MCK) strategic acquisitions and promising guidance raise optimism for the first quarter of fiscal 2018.

21 июля, 15:26

IDEXX Laboratories (IDXX) Q2 Earnings: A Beat in the Cards?

IDEXX Laboratories' (IDXX) Companion Animal Group business might drive its performance in Q2.

20 июля, 17:08

What's in Store for Express Scripts (ESRX) in Q2 Earnings?

Despite an upbeat guidance, cutthroat competition in the niche space is likely to mar Express Scripts' (ESRX) growth in the second quarter.

20 июля, 16:48

Baxter International (BAX) Q2 Earnings: What's in Store?

Despite an upbeat guidance, lower cyclophosphamide sales are likely to mar Baxter International (BAX) performance in the second quarter 2017.